1 Floras J S. Sympathetic activation in human heart failure: diverse mechanisms, therapeutic opportunities. Acta Physiol Scand, 2003, 177: 391-398？？
[2]
2 Lohse M J, Engelhardt S, Eschenhagen T. What is the role of beta-adrenergic signaling in heart failure. Circ Res, 2003, 93: 896-906？？
[3]
3 Singh K, Communal C, Sawyer D B, et al. Adrenergic regulation of myocardial apoptosis. Cardiovasc Res, 2000, 45: 713-719？？
[4]
4 Fowler M B, Laser J A, Hopkins G L, et al. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation, 1986, 74: 1290-1302
[5]
5 Goldspink D F, Burniston J G, Ellison G M, et al. Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways. Exp Physiol, 2004, 89: 407-416？？
[6]
6 Communal C, Singh K, Pimentel D R, et al. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation, 1998, 98: 1329-1334
[7]
7 Bos R, Mougenot N, Findji L, et al. Inhibition of catecholamine-induced cardiac fibrosis by an aldosterone antagonist. J Cardiovasc Pharmacol, 2005, 45: 8-13？？
[8]
8 Grassi G, Quarti-Trevano F, Dell''oro R, et al. Essential hypertension and the sympathetic nervous system. Neurol Sci, 2008, 29: S33-S36
[9]
9 Flaa A, Eide I K, Kjeldsen S E, et al. Sympathoadrenal stress reactivity is a predictor of future blood pressure: an 18-year follow-up study. Hypertension, 2008, 52: 336-341？？
[10]
10 Sharkey S W, Lesser J R, Zenovich A G, et al. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation, 2005, 111: 472-479？？
[11]
11 Ueyama T, Kasamatsu K, Hano T, et al. Emotional stress induces transient left ventricular hypocontraction in the rat via activation of cardiac adrenoceptors: a possible animal model of ''tako-tsubo'' cardiomyopathy. Circ J, 2002, 66: 712-713？？
[12]
12 Ueyama T, Senba E, Kasamatsu K, et al. Molecular mechanism of emotional stress-induced and catecholamine-induced heart attack. J Cardiovasc Pharmacol, 2003, 41: S115-118
[13]
13 Rona G, Chappel C I, Balazs T, et al. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. AMA Arch Pathol, 1959, 67: 443-455
[14]
14 Zbinden G, Moe R A. Pharmacological studies on heart muscle lesions induced by isoproterenol. Ann N Y Acad Sci, 1969, 156: 294-308？？
[15]
15 Kung H F, Blau M. Subcutaneous isoproterenol: a convenient rat model for early detection of myocardial necrosis. J Nucl Med, 1978, 19: 948-951
[16]
16 Kitagawa Y, Yamashita D, Ito H, et al. Reversible effects of isoproterenol-induced hypertrophy on in situ left ventricular function in rat hearts. Am J Physiol Heart Circ Physiol, 2004, 287: H277-285？？
[17]
17 Benjamin I J, Jalil J E, Tan L B, et al. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res, 1989, 65: 657-670
[18]
18 Clerk A, Michael A, Sugden P H. Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy. J Cell Biol, 1998, 142: 523-535
[19]
19 Bueno O F, De Windt L J, Tymitz K M, et al. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J, 2000, 19: 6341-6350？？
[20]
20 Ramirez M T, Sah V P, Zhao X L, et al. The MEKK-JNK pathway is stimulated by alpha1-adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy. J Biol Chem, 1997, 272: 14057-14061？？
[21]
21 Boluyt M O, Zheng J S, Younes A, et al. Rapamycin inhibits alpha 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes. Evidence for involvement of p70 S6 kinase. Circ Res, 1997, 81: 176-186
[22]
24 Pesce L, Comellas A, Sznajder J I. Beta-adrenergic agonists regulate Na-K-ATPase via p70S6k. Am J Physiol Lung Cell Mol Physiol, 2003, 285: L802-807
[23]
25 Dhalla N S, Temsah R M, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens, 2000, 18: 655-673？？
[24]
26 Zhang G X, Kimura S, Nishiyama A, et al. Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Cardiovasc Res, 2005, 65: 230-238？？
[25]
27 Ruperez M, Lorenzo O, Blanco-Colio L M, et al. Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis. Circulation, 2003, 108: 1499-1505？？
[26]
28 Wang J, Xu N, Feng X, et al. Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure. Circ Res, 2005, 97: 821-828？？
[27]
29 Liao W, Wang S, Han C, et al. 14-3-3 proteins regulate glycogen synthase 3beta phosphorylation and inhibit cardiomyocyte hypertrophy. FEBS J, 2005, 272: 1845-1854？？
[28]
30 Perrino C, Naga P S V, Mao L, et al. Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction. J Clin Invest, 2006, 116: 1547-1560？？
[29]
31 Han Y S, Tveita T, Kondratiev T V, et al. Changes in cardiovascular beta-adrenoceptor responses during hypothermia. Cryobiology, 2008, 57: 246-250？？
[30]
32 Kralova E, Mokran T, Murin J, et al. Electrocardiography in two models of isoproterenol-induced left ventricular remodeling. Physiol Res, 2008, 57: S83-89
[31]
33 Hohimer A R, Davis L E, Hatton D C. Repeated daily injections and osmotic pump infusion of isoproterenol cause similar increases in cardiac mass but have different effects on blood pressure. Can J Physiol Pharmacol, 2005, 83: 191-197？？
[32]
34 Freund C, Schmidt-Ullrich R, Baurand A, et al. Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo. Circulation, 2005, 111: 2319-2325？？
[33]
35 Xu Q, Dalic A, Fang L, et al. Myocardial oxidative stress contributes to transgenic beta-adrenoceptor activation-induced cardiomyopathy and heart failure. Br J Pharmacol, 2011, 162: 1012-1028？？
[34]
22 Sadoshima J, Izumo S. Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy. Circ Res, 1995, 77: 1040-1052
[35]
23 Hu Y, Zhang Y, Venkitaramani D V, et al. Translation of striatal-enriched protein tyrosine phosphatase (STEP) after beta1-adrenergic receptor stimulation. J Neurochem, 2007, 103: 531-541？？
